ArticleCureus2021
COVID-19 Reinfection.
Article in Cureus, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers, 2 of them syntheses that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
5 citing papers in PubMed, 2 syntheses or guidelines pooled it.
- Clinical manifestations, treatment options, and comorbidities in COVID-19 relapse patients: A systematic review.Journal of clinical laboratory analysis · 2022Pooled it
- SARS-CoV-2 Reinfection Is a New Challenge for the Effectiveness of Global Vaccination Campaign: A Systematic Review of Cases Reported in Literature.International journal of environmental research and public health · 2021Pooled it
- Clinical and epidemiological features of patients with COVID-19 reinfection: a systematic review.New microbes and new infections · 2022Review
- SARS-CoV-2: Reinfection after 18 Months of a Previous Case with Multiple Negative Nasopharyngeal Swab Tests and Positive Fecal Molecular Test.Medicina (Kaunas, Lithuania) · 2022Article
- Predictive determinants of overall survival among re-infected COVID-19 patients using the elastic-net regularized Cox proportional hazards model: a machine-learning algorithm.BMC public health · 2022Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The possibilities of coronavirus disease 2019 (COVID-19) to reinfect individuals have not been reported yet. All reported hypothesis of reinfection has been attributed to either relapse of the disease or having a mild course of symptoms. We report two cases of COVID-19 positive patients where they had complete resolution of symptoms and negative COVID-19 results. Weeks later, they returned with milder symptoms and a positive COVID-19 culture swab. In conclusion, early stages of COVID-19 where mild signs and symptoms are reported can be prolonged and the virus can stay dormant in the body for relapse later on.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.